powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1538357033
Michael Rogawski
M.D.
Neurology
Sacramento,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
PRESCRIBING · PART D · 2024
Total Rx claims
380
Beneficiaries
—
Total drug cost
$218K
Distinct drugs
12
Brand share
43.7%
Top prescribed drugs
Rimegepant Sulfate
70 claims
Amitriptyline Hcl
63 claims
Sumatriptan Succinate
48 claims
Atogepant
33 claims
Prochlorperazine Maleate
32 claims
QUALITY · MIPS · 2024
Final MIPS score
83.2
Quality
64.8
Cost
68.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.34%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$32K
Payment records
2
By payment type
Consulting Fee
$32K
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
48
Unique beneficiaries
—
Total services
59
Distinct HCPCS
3
Medicare payment
$3K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,670 Neurology providers in CA — bottom quintile (cohort median 581).
